CLO20-056: Real-Life Experience of Treatment With Anti-Programmed Cell Death-1 (PD-1) or Programmed Death-Ligand 1 (PD-L1) Antibodies in Patients With Non-Small Cells Lung Cancer (NSCLC)
2020 ◽
Vol 18
(3.5)
◽
pp. CLO20-056
Keyword(s):
2019 ◽
Vol 8
(S4)
◽
pp. S364-S368
◽
2017 ◽
Vol 60
(13)
◽
pp. 5857-5867
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 1090-1090
◽
2020 ◽
Vol 20
(9)
◽
pp. 1047-1059
◽
Keyword(s):
2018 ◽
Vol 10
(12)
◽
pp. 6711-6721
◽
2019 ◽
Vol 62
(15)
◽
pp. 7250-7263
◽
2019 ◽
Vol 19
(4)
◽
pp. 277
◽